Cargando…

Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway

PURPOSE: Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegia...

Descripción completa

Detalles Bibliográficos
Autores principales: Moshina, Nataliia, Falk, Ragnhild S., Botteri, Edoardo, Larsen, Marthe, Akslen, Lars A., Cairns, John A., Hofvind, Solveig
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547129/
https://www.ncbi.nlm.nih.gov/pubmed/34698976
http://dx.doi.org/10.1007/s11136-021-03017-7
_version_ 1784590324892434432
author Moshina, Nataliia
Falk, Ragnhild S.
Botteri, Edoardo
Larsen, Marthe
Akslen, Lars A.
Cairns, John A.
Hofvind, Solveig
author_facet Moshina, Nataliia
Falk, Ragnhild S.
Botteri, Edoardo
Larsen, Marthe
Akslen, Lars A.
Cairns, John A.
Hofvind, Solveig
author_sort Moshina, Nataliia
collection PubMed
description PURPOSE: Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegian women with symptomatic, screen-detected and interval breast cancer, and women without breast cancer and investigate quality adjusted life years (QALYs) for women with breast cancer from the third to 14th year since diagnosis. METHODS: This retrospective cross-sectional study was focused on women aged 50 and older. A self-reported questionnaire including EQ-5D-5L was sent to 11,500 women. Multivariable median regression was used to analyze the association between quality of life score (visual analogue scale 0–100) and detection mode. Health utility values representing women’s health status were extracted from EQ-5D-5L. QALYs were estimated by summing up the health utility values for women stratified by detection mode for each year between the third and the 14th year since breast cancer diagnosis, assuming that all women would survive. RESULTS: Adjusted regression analyses showed that women with screen-detected (n = 1206), interval cancer (n = 1005) and those without breast cancer (n = 1255) reported a higher median quality of life score using women with symptomatic cancer (n = 1021) as reference; 3.7 (95%CI 2.2–5.2), 2.3 (95%CI 0.7–3.8) and 4.8 (95%CI 3.3–6.4), respectively. Women with symptomatic, screen-detected and interval cancer would experience 9.5, 9.6 and 9.5 QALYs, respectively, between the third and the 14th year since diagnosis. CONCLUSION: Women with screen-detected or interval breast cancer reported better quality of life compared to women with symptomatic cancer. The findings add benefits of organized mammographic screening. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-03017-7.
format Online
Article
Text
id pubmed-8547129
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-85471292021-10-27 Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway Moshina, Nataliia Falk, Ragnhild S. Botteri, Edoardo Larsen, Marthe Akslen, Lars A. Cairns, John A. Hofvind, Solveig Qual Life Res Article PURPOSE: Breast cancers detected at screening need less aggressive treatment compared to breast cancers detected due to symptoms. The evidence on the quality of life associated with screen-detected versus symptomatic breast cancer is sparse. This study aimed to compare quality of life among Norwegian women with symptomatic, screen-detected and interval breast cancer, and women without breast cancer and investigate quality adjusted life years (QALYs) for women with breast cancer from the third to 14th year since diagnosis. METHODS: This retrospective cross-sectional study was focused on women aged 50 and older. A self-reported questionnaire including EQ-5D-5L was sent to 11,500 women. Multivariable median regression was used to analyze the association between quality of life score (visual analogue scale 0–100) and detection mode. Health utility values representing women’s health status were extracted from EQ-5D-5L. QALYs were estimated by summing up the health utility values for women stratified by detection mode for each year between the third and the 14th year since breast cancer diagnosis, assuming that all women would survive. RESULTS: Adjusted regression analyses showed that women with screen-detected (n = 1206), interval cancer (n = 1005) and those without breast cancer (n = 1255) reported a higher median quality of life score using women with symptomatic cancer (n = 1021) as reference; 3.7 (95%CI 2.2–5.2), 2.3 (95%CI 0.7–3.8) and 4.8 (95%CI 3.3–6.4), respectively. Women with symptomatic, screen-detected and interval cancer would experience 9.5, 9.6 and 9.5 QALYs, respectively, between the third and the 14th year since diagnosis. CONCLUSION: Women with screen-detected or interval breast cancer reported better quality of life compared to women with symptomatic cancer. The findings add benefits of organized mammographic screening. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11136-021-03017-7. Springer International Publishing 2021-10-26 2022 /pmc/articles/PMC8547129/ /pubmed/34698976 http://dx.doi.org/10.1007/s11136-021-03017-7 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Moshina, Nataliia
Falk, Ragnhild S.
Botteri, Edoardo
Larsen, Marthe
Akslen, Lars A.
Cairns, John A.
Hofvind, Solveig
Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
title Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
title_full Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
title_fullStr Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
title_full_unstemmed Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
title_short Quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from Norway
title_sort quality of life among women with symptomatic, screen-detected, and interval breast cancer, and for women without breast cancer: a retrospective cross-sectional study from norway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8547129/
https://www.ncbi.nlm.nih.gov/pubmed/34698976
http://dx.doi.org/10.1007/s11136-021-03017-7
work_keys_str_mv AT moshinanataliia qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway
AT falkragnhilds qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway
AT botteriedoardo qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway
AT larsenmarthe qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway
AT akslenlarsa qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway
AT cairnsjohna qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway
AT hofvindsolveig qualityoflifeamongwomenwithsymptomaticscreendetectedandintervalbreastcancerandforwomenwithoutbreastcanceraretrospectivecrosssectionalstudyfromnorway